# reload+after+2024-01-22 19:27:16.321245
address1§2150 St. ElzEar Boulevard West
city§Laval
state§QC
zip§H7L 4A8
country§Canada
phone§514 744 6792
website§https://www.bauschhealth.com
industry§Drug Manufacturers - Specialty & Generic
industryKey§drug-manufacturers-specialty-generic
industryDisp§Drug Manufacturers - Specialty & Generic
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was incorporated in 2013 and is headquartered in Laval, Canada.
fullTimeEmployees§19900
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Thomas J. Appio', 'age': 61, 'title': 'CEO & Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 4732816, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Seana  Carson', 'age': 51, 'title': 'Executive VP & General Counsel', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 720504, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John S. Barresi', 'age': 50, 'title': 'Senior VP, Controller, Chief Accounting Officer & Interim CFO', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mirza  Dautbegovic', 'title': 'Senior VP & COO', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Josh  Coyle', 'title': 'Senior Vice President of Sales & Salix', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kathleen  Fitzpatrick', 'title': 'Senior VP & Chief HR Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tage  Ramakrishna M.D.', 'age': 49, 'title': 'Chief Medical Officer and President of R&D', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeff  Hartness', 'title': 'Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Graham  Jackson', 'title': 'Senior VP & Chief Quality Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Cees  Heiman', 'title': 'Senior Vice President of Europe & Canada', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§5
boardRisk§2
compensationRisk§8
shareHolderRightsRisk§3
overallRisk§4
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
exDividendDate§1289347200
payoutRatio§0.0
fiveYearAvgDividendYield§6.52
beta§0.9
priceToSalesTrailing12Months§0.35082984
currency§USD
dateShortInterest§1702598400
forwardEps§3.82
pegRatio§0.88
lastDividendValue§1.0
lastDividendDate§1289347200
exchange§NYQ
quoteType§EQUITY
shortName§Bausch Health Companies Inc.
longName§Bausch Health Companies Inc.
firstTradeDateEpochUtc§764951400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§9e7b84f3-aa99-3efa-83c3-c9d91980d6fa
messageBoardId§finmb_345779
gmtOffSetMilliseconds§-18000000
targetHighPrice§16.0
targetLowPrice§6.0
targetMeanPrice§9.5
targetMedianPrice§8.0
recommendationMean§2.8
recommendationKey§hold
numberOfAnalystOpinions§6
quickRatio§0.641
grossMargins§0.70663
ebitdaMargins§0.33212003
trailingPegRatio§None
